We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov Menu

Diagnostic Value of C-reactive Protein for Detection of Postoperative Inflammatory Complications After Gastroesophageal Cancer Surgery

This study has been completed.
ClinicalTrials.gov Identifier:
First Posted: November 30, 2010
Last Update Posted: December 10, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Cantonal Hospital of St. Gallen
Although widely used, there is a lack of evidence concerning diagnostic value of C-reactive protein (CRP) in the postoperative course. The aim of this study was to evaluate the diagnostic accuracy of CRP for postoperative inflammatory complications after gastroesophageal cancer.

Condition Intervention
Given Indication for Gastroesophageal Cancer Surgery Other: gastroesophageal cancer surgery

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective

Further study details as provided by Cantonal Hospital of St. Gallen:

Primary Outcome Measures:
  • postoperative Inflammatory complications [ Time Frame: 30 days postoperatively ]

Estimated Enrollment: 200
Study Start Date: December 2010
Study Completion Date: December 2010
Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Patients after gastroesophageal cancer surgery Other: gastroesophageal cancer surgery
gastroesophageal cancer surgery


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Given indication for gastroesophageal cancer surgery

Inclusion Criteria:

  • all patients with gastroesophageal cancer surgery

Exclusion Criteria:

  • lack of measurement of C-reactive protein
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01249534

Department of surgery
St. Gallen, Switzerland, 9007
Sponsors and Collaborators
Cantonal Hospital of St. Gallen
Principal Investigator: Rene Warschkow, MD Cantonal Hospital St. Gallen
  More Information

Responsible Party: Rene Warschkow, MD, Kantonal Hospital St. Gallen, Department of Visceral Surgery
ClinicalTrials.gov Identifier: NCT01249534     History of Changes
Other Study ID Numbers: EKSG10/144
First Submitted: November 29, 2010
First Posted: November 30, 2010
Last Update Posted: December 10, 2010
Last Verified: November 2010